患者入口
工作流程
德国的
医疗保健
记事
协议(科学)
门静脉
医学
心理学
知识管理
计算机科学
外科
替代医学
病理
内科学
考古
数据库
经济
历史
经济增长
作者
Florian Wurster,Paola Di Gion,Nina Goldberg,Volker Hautsch,Klara Hefter,Christin Leminski,Georg Langebartels,Holger Pfaff,Ute Karbach
标识
DOI:10.1186/s43058-024-00614-8
摘要
Abstract Background German hospitals are legally obliged to implement digital patient portals within the next years. Systematic reviews show that the use of patient portals may be associated with improved patient-centeredness and workflows. However, mandatory digital healthcare innovations are sometimes not used by the target group as planned or even completely rejected. Based on Roger's theory of innovation diffusion, it can be assumed that the time factor is of particular importance for the adoption of the patient portal. The aim of the project is to assess determinants of patient portal adoption and to examine whether Roger’s theory can be confirmed. Methods The project investigates the use of the patient portal in three different clinics of a large academic teaching hospital in Germany using a longitudinal study design with three cross-sectional time points (pre, post, post). Doctors and patients are surveyed about factors that predict the use of the patient portal and whether the strength of these factors changes over time. They are also interviewed about possible barriers they experience when using the patient portal or about the reasons why the patient portal is not used. Regression models and content analyses are used to answer the research questions. Discussion Determinants of patient portal use will be discussed under the light of the temporal component of Roger's theory. At the same time, it is expected that some determinants will remain unchanged over time. Identifying determinants independent of time allows targeting the groups, enabling specific communication strategies to empower these groups to use the patient portal, contributing to an equal health care system. Trial registration The study was prospectively registered in the German register of clinical trials (DRKS00033125) in May 2024.
科研通智能强力驱动
Strongly Powered by AbleSci AI